mTHPC |
In-Vivo
|
High tumoral accumulation of the PS was observed in rat liver metastases with respect to the normal liver; extensive tumor tissue damage upon illumination; mild and transient damage to normal tissue was observed. |
[41] |
Photofrin, mTHPC, and mTHPBC |
In-Vivo
|
Upon illumination, near-infrared PS mTHPBC showed significantly larger necrotic areas than the others in normal rat livers; highlight the advantage of near-infrared PS activation for pigmented tissues like the liver. |
[43] |
New nanocarrier containing IR780 |
In-Vitro and in-vivo
|
IR780 and Paclitaxel (chemotherapeutic drug) loaded nanocarriers exhibited synergistic effect by inducing cancer cell apoptosis and cell cycle arrest at the G2/M phase for HCC; the combined treatment inhibited the in-vivo tumor growth and the tumor angiogenesis. |
[44] |
Chlorin e6 containing gold nanoparticles |
In-Vitro and in-vivo
|
PDT coupled with hypoxia-induced chemotherapy showed a synergistic anti-HCC effect. |
[45] |
ICG-loaded lactosomes |
In-Vitro and in-vivo
|
ICG-lactosome PDT treated HCC cells have higher cytotoxicity than ICG PDT; ICG-lactosome had higher fluorescence of tumor areas than ICG alone, along with anti-neoplastic effects on these malignant implants. |
[46] |
5-ALA |
In-Vitro and in-vivo
|
In-Vitro and in-vivo PpIX fluorescence was detected in tumors; red fluorescence was detected in HCC patient samples who were orally administered with 5-ALA before resection. |
[47] |
5-ALA |
In-Vivo
|
Higher PpIX fluorescence intensity was detected in HCC than in non-tumoral tissues in Male Fisher-344 rats; PDT induced necrosis in tumoral tissue; no necrosis was evident in non-tumoral tissue. |
[48] |
Deuteporfin |
In-Vivo
|
PDT can inhibit mouse hepatoma growth and induce an anti-tumor immune response. |
[49] |
Pheophorbide-a |
In-Vitro
|
PDT caused tumoral cytotoxicity of HCC cell lines by induction of apoptosis; PDT-induced immunogenicity triggered phagocytic capture of HCC cell lines by human macrophages. |
[50] |